Salesforce: Positive On Price Hikes

Summary:

  • Salesforce has revealed its intention to raise its list prices next month, and the recent price hikes have come in tandem with the company’s launch of new AI offerings.
  • CRM guided that its normalized operating margin could rise to 30% in Q1 FY 2025, and pricing is expected to be a key profitability improvement lever going forward.
  • My Buy rating for Salesforce stock stays intact; CRM has the potential to deliver meaningful profit margin expansion in the future considering its recent move to increase prices.
A view of the Salesforce West entrance on Mission Street on the first day of the Dreamforce 2017 conference.

Bjorn Bakstad

Elevator Pitch

I continue to assign a Buy rating to Salesforce, Inc. (NYSE:CRM) stock. With my earlier write-up published on June 7, 2022, I reviewed CRM’s financial results for the first quarter of fiscal 2023 (YE January 31).

In the


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e. buying assets at a discount e.g. net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e. buying earnings power at a discount in great companies like “Magic Formula” stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get started today!

Leave a Reply

Your email address will not be published. Required fields are marked *